ABSTRACT G-protein-coupled receptor activation is generally analyzed under equilibrium conditions. However, real-life receptor functions are often dependent on very short, transient stimuli that may not allow the achievement of a steady state. This is particularly true for synaptic receptors such as the ␣ 2A -adrenergic receptor (␣ 2A -AR). Therefore, we developed a fluorescence resonance energy transfer-based technology to study nonequilibrium ␣ 2A -AR function in living cells. To examine the effects of increasing concentrations of the endogenous agonist norepinephrine on the speed and extent of ␣ 2A -AR activation with very high temporal resolution, we took advantage of a fluorophore-containing ␣ 2A -AR sensor. The results indicated that the efficacy of norepinephrine in eliciting receptor activation increased in a time-dependent way, reaching the maximum with a half-life of ϳ60 ms. The EC 50 values under nonequilibrium conditions start at ϳ26 M (at 40 ms) and show a 10-fold decrease until the steady state is achieved. To analyze the ability of norepinephrine to trigger a downstream intracellular response after ␣ 2A -AR stimulation, we monitored the kinetics and amplitude of G i activation in real time by using a fluorophore-containing G i sensor. The results show that both the efficacy and the potency of norepinephrine in inducing G i activation achieve a steady state more slowly, compared with receptor activation, and that the initial EC 50 value of ϳ100 nM decreases in an exponential way, reaching the minimal value of ϳ10 nM at equilibrium. Therefore, both the efficacy and the potency of norepinephrine increase ϳ10-fold over a few seconds of agonist stimulation, which illustrates that receptor and G-protein signaling and signal amplification are highly timedependent phenomena.
Introduction
G-protein-coupled receptors (GPCRs) represent the largest family of membrane receptors for a large number of diverse endogenous ligands, including hormones and neurotransmitters (Lefkowitz, 2000) . The binding of an extracellular agonist to its receptor represents the initial step in the signaling pathway and has typically been investigated through radioligand binding experiments. Such studies allow the determination of equilibrium affinities (K i and K d values) and also yield important details about ligand association/dissociation rates at the receptor level (Hulme and Trevethick, 2010) . However, such experiments require long incubation times (from several minutes to hours) and thus cannot represent a real-time approach. Furthermore, binding studies are limited to the interactions between ligands and receptors and cannot explore the activation of a receptor once it is bound to an agonist. After the binding of an extracellular agonist to its GPCR, the signaling pathway proceeds with the receptor switching from a resting state into an active conformation that allows the binding and activation of the cognate G-proteins and, hence, the transduction of a transmembrane signal to the downstream effectors (e.g., adenylyl cyclases, phospholipases, or ion channels). Because the agonist-induced receptor conformational rearrangements were not directly accessible until recently, GPCR activation was inferred traditionally from the stimulation of a receptor-mediated downstream biological response that could be easily measured experimentally. Together with binding assays, such activation assays led to the classic concepts of receptor theory. Most methods applied for these studies do not use intact cells and are usually performed under equilibrium conditions necessitating extended incubation times, which do not allow continuous, real-time monitoring of receptor activity. Under physiological conditions, however, receptor binding and activation often are dependent on very short stimuli and usually do not reach a steady state. This is especially true for receptors involved in synaptic transmission, such as ␣ 2A -adrenergic receptors (␣ 2A -ARs). These rhodopsin-like GPCRs mediate the biological effects of endogenous catecholamines, most notably in presynaptic control of neurotransmitter release, thus playing a key role in the modulation of many physiological functions of the sympathetic nervous system (Philipp and Hein, 2004; Hein, 2006) . Norepinephrine is the principal neurotransmitter of postganglionic sympathetic nerves. Once released, it diffuses across the synaptic space and exerts its function by binding to and activating either presynaptic ␣ 2A -ARs on the nerve ending or postsynaptic ␣ 2A -ARs on the effector organ. Fast cyclic voltammetry measurements in multiple brain regions have shown that the maximal evoked norepinephrine release in vivo is in the micromolar range and that the time required for the overflow to decay to half of the maximum is a few seconds (Park et al., 2009 (Park et al., , 2011 .
Because the physiological dynamics of norepinephrine are not compatible with the classic approaches applied to detect receptor activation, we developed a technology to study nonequilibrium ␣ 2A -AR function in real time. The development of optical techniques that permit the study of GPCR-mediated signaling processes in intact cells facilitates the analysis of distinct signaling steps in a more-physiological setting (reviewed by Lohse et al., 2008b) . By taking advantage of a fluorescence resonance energy transfer (FRET)-based approach, it is possible to follow the conformational changes of GPCRs in living cells and to gain information about the characteristics and kinetics of GPCR activation in real time (Vilardaga et al., 2003) . Placement of a donor fluorophore [e.g., cyan fluorescent protein (CFP)] and an acceptor fluorophore [e.g., small fluorescein arsenical hairpin binder (FlAsH)] in the third intracellular loop and at the C terminus, respectively, led to the development of an ␣ 2A -AR sensor ( Fig. 1 ) whose activation can be measured through intramolecular FRET recording. Kinetic measurements suggested previously that, given enough receptors and G-proteins, the receptor-G-protein interaction occurs as fast as receptor activation itself and therefore does not represent a time-limiting step in the signaling pathway (Hein et al., 2005 . In contrast, the subsequent G-protein activation limits the progression of the receptor-mediated signaling cascade Hein et al., 2006; Jensen et al., 2009) ; although receptor-G-protein interactions are already maximal after ϳ50 ms, only a small fraction of G-proteins are activated at that point, and it takes ϳ1 to 2 s until G-protein activation reaches its maximum.
These new techniques allow the study of receptor activation and signaling and thus the investigation of potencies and efficacies under nonequilibrium conditions. Here, taking advantage of both receptor and G-protein FRET-based sensors, we analyzed norepinephrine-induced ␣ 2A -AR activation under nonequilibrium conditions. This approach allowed the real-time monitoring of norepinephrine-mediated effects occurring on a millisecond time scale in living cells, which reflect physiological synaptic events. were described previously . HEK-293 cells were transfected with plasmids encoding the wild-type ␣ 2A -AR and the heterotrimeric G i CFP/YFP sensor by using Effectene (QIAGEN, Hilden, Germany). The amount of cDNA used for transient transfection of the wild-type ␣ 2A -AR was chosen to yield overall similar receptor expression (ϳ2 pmol/mg), as determined through radioligand binding experiments.
Materials and Methods

Materials
FlAsH Labeling. FlAsH labeling was performed as described previously . In brief, ␣ 2A -AR FlAsH/CFPexpressing HEK-293 cells were washed twice with phenol red-free Hanks' balanced salt solution (HBSS) containing 1 g/liter glucose (Invitrogen) and subsequently were incubated for 1 h at 37°C with 500 nM FlAsH suspended in HBSS containing 12.5 M 1,2-ethanedithiol. To reduce nonspecific labeling, cells were washed with HBSS, incubated at 37°C for 10 min with HBSS containing 250 M ethanedithiol, and again rinsed twice with HBSS before being used for fluorescence measurements. We showed earlier that this labeling procedure does not interfere with the kinetic properties of the labeled receptors .
Fluorescence Measurements. FRET experiments were performed with whole cells as described previously (Vilardaga et al., 2003 Hoffmann et al., 2005; Nikolaev et al., 2006; Zü rn et al., 2009; Maier-Peuschel et al., 2010; Reiner et al., 2010) . In brief, transfected cells grown on coverslips were washed with HBSS and maintained in buffer A (140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM HEPES, pH 7.3) at room temperature. Coverslips were mounted on an Attofluor holder (Invitrogen) and placed on a Zeiss inverted microscope (Axiovert 135; Carl Zeiss GmbH, Jena, Germany) equipped with an oil-immersion, 100ϫ objective and a dual-emission photometric system (TILL Photonics, Grä felfing, Germany). Samples were excited with light from a polychrome IV system (TILL Photonics). To minimize photobleaching and to enable fast temporal resolution, the illumination and recording times were set to 14 to 40 ms and 20 to 100 ms, respectively. FRET was monitored as the YFP/CFP or FlAsH/CFP emission ratio, F 535 /F 480 , where F 535 and F 480 are the emission intensities at 535 Ϯ 15 nm and 480 Ϯ 20 nm (beam-splitter, long wave pass dichroic, 505 nm), respectively, upon excitation at 436 Ϯ 10 nm (beam-splitter, long wave pass dichroic, 460 nm). Special care was taken to ensure similar fluorescence levels and distributions in the examined cells. The emission ratio was corrected with respect to the spillover of CFP fluorescence into the 535-nm channel (spillover of FlAsH and YFP fluorescence into the 480-nm channel was negligible), to yield a corrected ratio of F 535 ‫ء‬ /F 480 ‫ء‬ . The FlAsH (or YFP) emission upon excitation at 480 nm was recorded for each experiment, for subtraction of direct excitation from the corrected ratio. For determination of agonist-induced changes in FRET, cells were continuously superfused with buffer A, and single concentrations of norepinephrine were applied by using a computer-assisted, solenoid valve-controlled, rapid superfusion device (ALA-VM8; ALA Scientific Instruments, Westbury, NY) (solution exchange, 5-10 ms). Signals detected with avalanche photodiodes were digitized by using an analog-to-digital converter (Digidata 1322A; Molecular Devices, Sunnyvale, CA) and were stored on a personal computer by using Clampex 8.1 software (Molecular Devices). The agonist-induced decrease in the FRET ratio was fitted to the equation
Ϫt/ , where is the time constant (in milliseconds) and A is the amplitude of the signal.
Results
To investigate the effects of different concentrations of the full agonist norepinephrine on the speed and extent of ␣ 2A -AR activation in real time, we used a FRET approach, taking advantage of the fully functional ␣ 2A -AR FlAsH/CFP FRET sensor (Fig. 1A) Nikolaev et al., 2006 (Fig. 1A, right) . This FRET change reveals the full agonist-induced receptor activation and typically occurs on a millisecond time scale (Vilardaga et al., 2003) . The maximal FRET response was high (⌬F FlAsH ‫ء‬ /F CFP ‫ء‬ of ϳ20%); therefore, superfusion of cells even with low concentrations of norepinephrine produced FRET responses with high signal/noise ratios. Figure 2A shows that stimulation with increasing concentrations of the agonist (norepinephrine at 1 M to 1 mM) led to correspondingly increasing FRET signals (as a reference for full receptor activation for each experiment, the response was normalized to the effects of 1 mM norepinephrine at times of Ͼ2 s). The time to the half-maximal FRET response was variable and depended on the degree of receptor activation, with a saturation value for the rate constant of ϳ60 ms, which was achieved at high agonist concentrations (Fig. 2B) .
Because the FRET-based approach applied here represents a unique tool to monitor receptor conformational changes in real time, we were able to determine the speed and extent of agonistinduced receptor activation every 20 ms. By using those FRET data, we established a pool of time-dependent concentrationresponse curves (a selection is shown in Fig. 3 ), which show EC 50 values (i.e., effective norepinephrine concentrations evoking 50% of the maximal response) that clearly moved to the left over time until the steady state was achieved (Ͼ2 s) (Table 1) . Similar to the potency, the efficacy of norepinephrine in eliciting ␣ 2A -AR FlAsH/CFP activation increased in a time-dependent manner and then reached a saturation value (which was set to 100%).
To analyze in real time the ability of increasing concentrations of norepinephrine to produce a downstream intracellular response after ␣ 2A -AR stimulation, we analyzed the kinetics and the amplitude of G i activation in single intact cells. For this purpose, we transfected HEK-293 cells expressing the ␣ 2A -AR with the well characterized G i CFP/YFP sensor that consists of the three subunits G␣ i1 YFP , G␤ 1 , and G␥ 2 CFP (Fig. 1B) . As shown previously, stimulation with saturating concentrations of norepinephrine triggers a robust FRET decrease (⌬F YFP ‫ء‬ /F CFP ‫ء‬ ), which is significantly slower than the maximal speed of receptor activation (Fig. 1B, right) . Figure 4 represents the time-resolved FRET changes of G i activation induced by norepinephrine concentrations ranging from 1 nM to 1 mM. For each experiment, the FRET change was normalized to the maximal effect achieved with saturating concentrations of norepinephrine. In agreement with data published previously , the amplitude of G i activation achieved maximal values only at higher agonist concentrations (Fig. 4A) . Likewise, the speed of G i activation increased with increasing concentrations of norepinephrine, reaching the minimal value of ϳ600 ms at saturating concentrations of the agonist (Fig. 4B) . To investigate how the potency and efficacy of norepinephrine in triggering G i activation change under nonequilibrium conditions, we developed a series of concentration-response curves for G i activation, starting with the FRET data recorded 100 ms after agonist superfusion and proceeding every 100 ms until the steady state was reached. As shown in Fig. 5 , both the potency and the efficacy of norepinephrine at the G-protein level depended strongly on time and reached the maximal values only under equilibrium conditions (times of Ͼ10 s). The changes in potency were best seen in the decreases in the EC 50 values presented in Table 2 .
A comparison of the time-dependent, norepinephrine-mediated effects at the ␣ 2A -AR and G i -protein levels is summarized in Fig. 6 . As shown, the efficacy of norepinephrine at the receptor level reached its maximum with an apparent half-life of 58 Ϯ 3 ms (Fig. 6A) , whereas the E max values at the G i -protein level followed two-phase kinetics, with a faster component and a slower component (half-lives of 128 Ϯ 60 ms and 658 Ϯ 40 ms, respectively). Figure 6B , top, shows the time-dependent potency of norepinephrine at the receptor level. The EC 50 values decreased with a half-life of 330 Ϯ 11 ms, starting at ϳ26 M (40 ms after norepinephrine superfusion) and reaching ϳ2 M at steady state. As depicted in Fig. 6B , bottom, the EC 50 values relative to G i activation also decreased in a time-dependent manner but reached the steady state with a half-life of 2520 Ϯ 168 ms. The potency of the full agonist norepinephrine in eliciting G i activation started at ϳ100 nM after a 100-ms pulse of norepinephrine and increased exponentially until equilibrium was achieved. In the latter condition, the EC 50 value was ϳ10 nM. The relationship between the potency of norepinephrine at the receptor and G-protein levels is presented in Fig. 6C , which indicates a large time-dependent amplification of the agonist-induced signal at the ␣ 2A -AR.
Discussion
Classic receptor theory is largely based on in vitro measurements in which the receptor is exposed to a constant concentration of ligand under steady-state conditions (Clark, Table 1 . NE, norepinephrine. Molinoff et al., 1981; Weiland and Molinoff, 1981; Black et al., 1985; Kenakin, 2002) . Because a failure to attain equilibrium would lead to underestimation of ligand binding and receptor activation ability, such studies usually require long incubation times (Hulme and Trevethick, 2010) . Both the theory and experimental data on the kinetics of ligand binding to receptors indicate that these processes depend on ligand concentrations (e.g., Hulme and Trevethick, 2010).
These assay conditions only poorly mimic the concentrations and duration of exposure that the agonist exerts against its target in an in vivo setting. In fact, under physiological conditions (i.e., in response to nerve activity), stimulation of ␣ 2A -ARs may be very short-lived but in response to high agonist concentrations. For example, it has been estimated that, in neurovascular junctions, norepinephrine concentrations might be in excess of 100 M but for times as short as 100 ms (Bevan et al., 1984 (Bevan et al., , 1987 . These short stimulation pulses with high norepinephrine concentrations result from the rapid release of norepinephrine from vesicles, where its concentrations can exceed several hundred millimolar, followed by rapid reuptake (Philippu and Matthaei, 1988) . To date, however, no techniques have been available for assessment of ligand binding with sufficient speed or assessment of the resultant receptor activation in real time, with the exception of the ion channel receptors, for which many kinetic experiments have been performed and theories developed (notably by Colquhoun, 2007) .
To study the characteristics and kinetics of GPCR activation in a more native environment, we developed a FRETbased approach, which enables the detection of the fast activation of the receptors and their cognate G-proteins in intact cells (Lohse et al., 2008a) . Here, taking advantage of those FRET-based sensors, we were able to monitor nonequilib- Fig. 2A , the FRET changes were calculated as percentages of the maximal response triggered by norepinephrine at 1 mM at equilibrium, which was assayed in each individual experiment as a reference. B, activation time constants plotted as a function of norepinephrine concentration. Values were obtained by fitting the kinetic recordings to a monoexponential equation. At saturating concentrations of norepinephrine, the speed of receptor-mediated G-protein activation was ϳ600 ms. For each norepinephrine concentration, data are mean Ϯ S.E. values for 8 to 14 independent cells. Fig. 5 . Concentration-response curves for G i activation under nonequilibrium conditions and at steady state. The values corresponding to the FRET amplitudes that were recorded every 100 ms until the steady state was reached (Fig. 4) were fitted with a sigmoidal concentration-response model and plotted as a function of norepinephrine (NE) concentration. A selection of the most significant curves is shown here, and the corresponding EC 50 values are presented in Table 2 . (Vilardaga et al., 2003 Hoffmann et al., 2005) . First, they confirm that the extent of the FRET change is proportional to the superfused concentration of agonist, with saturating concentrations of norepinephrine triggering the maximal FRET decrease (Fig. 2A) . Next, they support the notion that the speed of receptor activation depends strongly on agonist concentrations, with higher concentrations of norepinephrine triggering FRET changes more rapidly until a saturation value of ϳ60 ms is reached; this value presumably represents the upper limit of the true activation time of the ␣ 2A -AR (Fig. 2B) .
The large FRET responses and the high signal/noise ratios characterizing the ␣ 2A -AR FlAsh/CFP sensor allowed us to monitor the agonist-dependent receptor activation with very high temporal resolution, recording the fluorescence emissions of the donor and acceptor fluorophores every 20 ms. Therefore, we were able to establish a pool of concentration-response curves under nonequilibrium conditions (Fig. 3) . As expected, the efficacy of norepinephrine in eliciting ␣ 2A -AR FlAsH/CFP activation increased in a time-dependent manner and reached its maximum with an apparent half-life of ϳ60 ms (Fig. 6A ). As presented in Fig. 6B , top, the corresponding EC 50 values decreased in an exponential manner, reaching ϳ2 M at steady state. The equilibrium EC 50 value of 2 M is high, compared with potencies determined in other types of functional experiments, but it is similar to the affinity of the low-affinity state of the ␣ 2A -AR, which we determined previously by performing radioligand binding experiments with cell membranes (Vilardaga et al., 2003; Nikolaev et al., 2006) . It most likely represents the true affinity of the receptor in intact cells (i.e., in the non-G-protein-bound state). These observations correlate well with the apparent lack of a "receptor reserve" noted when receptor activation was monitored in intact cells.
In the GPCR signaling pathway, the interaction of an agonist-activated receptor with the cognate G-protein results in activation of the G-protein. To evaluate ␣ 2A -AR activation through a receptor-mediated downstream biological response, we took advantage of a G i CFP/YFP sensor, which allows direct, real-time measurement of G i activation. The G i CFP/YFP sensor gives rise to FRET responses that show relatively high signal/noise ratios, which allow the recording of FRET values every 100 ms. As expected, the amplitude of the FRET changes depended on agonist concentrations, and the time courses of G i activation reached maximal values only at high norepinephrine concentrations (Fig. 4) . The ϳ10-fold slower speed of G i activation, compared with receptor activation, is in agreement with earlier data that suggest that G-protein activation is the rate-limiting step in the activation of the signaling cascade (Hein et al., 2005 . The development of nonequilibrium concentration-response curves by using the FRET data on G i activation confirms that, with our FRET-based approach in intact cells, we can experimentally reproduce the classic receptor theory predictions. As depicted in Fig. 6A , the efficacy of norepinephrine in activating the cognate G i -protein increased until equilibrium was achieved. Here, in contrast to the receptor activation kinetics, the E max values followed two-phase kinetics, which agree very well with the notion that, after rapid G-protein recruitment to the activated receptor, a slow step (probably GDP release from the G-protein) limits the speed of G-protein activation, which makes it the time-limiting step of the signaling cascade . As shown in Fig. 6B , bottom, the EC 50 values for G i activation decreased in a time-dependent manner and reached the steady state ϳ8 times more slowly than shown for activation of the receptor. The equilibrium EC 50 value of the full agonist norepinephrine in eliciting G i activation was ϳ10 nM, in accordance with a high degree of receptor reserve existing in our transfected cell system and corresponding to the presence of a large receptor reserve identified in electrophysiological studies with transfected cells (Bü nemann et al., 2001) .
A comparison of the two panels in Fig. 6B reveals the differences in norepinephrine concentrations required to elicit half-maximal responses for the receptor and for G i . As shown in Fig. 6C , these data illustrate that, over short stimulation phases, the amplification between receptors and Gproteins first becomes smaller, because receptors initially are activated faster than G i , but then continues to increase until it achieves 2.5 orders of magnitude. This large amplification demonstrates a large receptor reserve, which means that only a fraction of the receptors available on the cell membrane need to be activated to generate a maximal downstream signaling effect (Nickerson, 1956; Ariens et al., 1960) . This concept has been much discussed on the basis of various types of analyses of neurotransmitter release experiments (Agneter et al., 1993 (Agneter et al., , 1997 . Many biological systems involving ␣ 2A -ARs have been reported to display large receptor reserves, including presynaptic control of neurotransmitter release in various brain regions (Adler et al., 1987) , prejunctional receptors at the vas deferens (Sallés et al., 1994) , receptors on human platelets (Lenox et al., 1985) , receptors controlling venous (but not arterial) tone (Ruffolo, 1986) , and receptors controlling behavioral and physiological responses (Durcan et al., 1994) . Our data now show that the signal amplification underlying the receptor reserve is time-dependent and increases, in our case, by almost 1 order of magnitude over a period of ϳ15 s.
In conclusion, the high temporal resolution achieved with our FRET-based technology was successfully applied to monitor norepinephrine-mediated effects on ␣ 2A -AR activation and signaling in real time. Taken together, our experimental findings reflect well the physiological synaptic events and resemble the theoretical predictions of classic receptor theory, which postulate that, under nonequilibrium conditions, higher agonist concentrations are required to achieve receptor binding and activation (Convents et al., 1987; Severne et al., 1987) . Over stimulation times of less than 1 s, agonist potency and efficacy at the receptor increase, followed by similar increases at the level of G i that occur over a few seconds. Therefore, receptor-mediated signaling and signal amplification are highly dependent on stimulation times. This adds another level of complexity to agonist effects at G-protein-coupled receptors.
